Pig organ transplants may soon surpass the quality and effectiveness of human donor organs — a development that could revolutionize the field of transplantation. But here's where it gets controversial: could pig organs actually become better than human ones? A prominent surgeon involved in pioneering pig-to-human organ transplants claims that someday, pig organs might not only match but potentially exceed their human counterparts.
Dr. Robert Montgomery, who leads the Transplant Institute at NYU Langone, has already performed the very first pig kidney transplant into a living human as part of a groundbreaking trial. This initial procedure has set the stage for additional transplants, with the next one scheduled for January. The plan is to initially involve six patients, all receiving organs that have been genetically modified to reduce the risk of rejection — specifically, pig organs edited in ten different places to make them more compatible with the human immune system.
If regulatory approval from the U.S. Food and Drug Administration (FDA) comes through, the trial will expand significantly, involving an additional 44 patients. This approach, called xenotransplantation, is seen as a promising solution to the staggering shortage of human donor organs. According to NHS Blood and Transplant, more than 12,000 individuals in the UK alone have either died or been removed from transplant waiting lists over the past decade because suitable organs were not available.
Participants in the current trial include those who either cannot qualify for a human kidney transplant or are on waiting lists but have a high risk of dying or remaining untransplanted within five years. Dr. Montgomery emphasizes the grim reality faced by many needing transplants, stating, "There's just never going to be enough human organs," pointing to the immense scarcity due to limited supply.
Montgomery’s own journey gives him profound insight into the urgency of increasing organ availability. He has inherited a heart condition called dilated cardiomyopathy, which tragically claimed his father and brother. After suffering seven cardiac arrests and spending a month in a coma, he received his own heart transplant in 2018. His personal experience fuels his passion for expanding transplant options and overcoming the chronic shortages.
Throughout his career, Montgomery has pioneered various innovative strategies to boost the supply of human organs. For instance, he's been involved in domino kidney transplants — a technique where incompatible donors are linked in chains to maximize the case for compatible matches, effectively increasing transplant opportunities. Additionally, he's led efforts to use organs from donors with hepatitis C, treating recipients afterward with medication to clear the infection, and he even accepted a hepatitis C-positive heart for his own transplant.
Despite these advances, Montgomery recognizes the limitations of current methods. "We’ve tried to gradually increase the number of available human organs, but progress has been slow and often offset by the growing number of patients waiting for transplants," he notes. This frustration has propelled him to explore entirely new pathways, like xenotransplantation.
Recent technological developments, especially the ability to genetically modify pigs, have been game-changers. Montgomery points out that although xenotransplantation was once dismissed as science fiction or a distant dream, these breakthroughs have made it a feasible reality today. He performed the world’s first gene-edited pig kidney transplant into a human in 2021, which was a significant milestone. Although the recipient was brain-dead, the experiment proved crucial — showing that pig organs could function without immediate rejection and providing essential safety data to move forward.
Looking ahead, Montgomery suggests that pig organs might not just serve as substitutes but could potentially achieve superiority through further genetic modifications. For example, tweaking pig organs could make them more compatible or resistant to rejection, possibly leading to organs that are better than natural human organs because they can be continuously optimized — a feat impossible with human donors.
Some research, including studies led by Montgomery, indicates that transplanting additional pig organs such as the thymus — an organ vital for developing immune cells — alongside kidneys might improve tolerance, reducing or even eliminating the need for anti-rejection drugs in the future. Such advancements could dramatically change transplant medicine, making long-term success more achievable.
While xenotransplantation has seen previous attempts, mostly involving patients already in critical condition, the new clinical trial marks the first structured effort to transplant pig organs into living, healthy individuals. Past cases have resulted in some recipients needing organ removal or passing away, but notably, two patients are still living with pig kidneys. There’s particular excitement about kidneys and hearts, which seem to be the most promising candidates for success, whereas lungs and livers still pose significant challenges, with the latter remaining a subject of ongoing research.
Montgomery admits he wouldn’t hesitate to personally receive a pig heart if he needed one in the future. "If I remain healthy and alive, I’d definitely consider it," he states. His motivation is deeply personal — he hopes to give his children, who share his genetic condition, better options than those available to his family in the past.
The future of xenotransplantation is filled with promise and controversy alike. As this innovative approach moves closer to mainstream application, many questions arise about ethics, safety, and long-term outcomes. Do you believe pig organs could become the norm in organ transplantation someday? Or do you see potential risks and ethical dilemmas that might outweigh the benefits? Share your thoughts and join the conversation.
